Cargando…

Extensively Drug-Resistant Tuberculosis, China

Detalles Bibliográficos
Autores principales:	Tang, Shenjie, Zhang, Qing, Yu, Jinming, Liu, Yidian, Sha, Wei, Sun, Hua, Fan, Lin, Gu, Jin, Hao, Xiaohui, Yao, Lan, Xiao, Heping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2011
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166004/ https://www.ncbi.nlm.nih.gov/pubmed/21392462 http://dx.doi.org/10.3201/eid1703.100919

Ejemplares similares

Extensively Drug-Resistant Tuberculosis,Taiwan
por: Yu, Ming-Chih, et al.
Publicado: (2008)

Extensively Drug-Resistant Tuberculosis, Central China, 2007–2009
por: Shi, Dawei, et al.
Publicado: (2012)

Extensively Drug-Resistant Tuberculosis, Lesotho
por: Satti, Hind, et al.
Publicado: (2008)

Spread of Extensively Drug-resistant Tuberculosis
por: Samper, Sofía, et al.
Publicado: (2007)

Extensively Drug-Resistant Mycobacterium tuberculosis, India
por: Mondal, Rajesh, et al.
Publicado: (2007)

Extensively Drug-resistant Tuberculosis, Italy and Germany
por: Migliori, Giovanni Battista, et al.
Publicado: (2007)

Prevalence of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Patients with Pulmonary Tuberculosis in Zahedan, Southeastern Iran
por: Metanat, M, et al.
Publicado: (2012)

Outcomes associated with standardized treatment regimens for extensively drug-resistant tuberculosis
por: Aggarwal, Anivita, et al.
Publicado: (2020)

Beijing genotype of Mycobacterium tuberculosis is associated with extensively drug-resistant tuberculosis: A global analysis
por: Keikha, M., et al.
Publicado: (2021)

Extensively Drug-Resistant Tuberculosis in the Time of COVID-19—How has the Landscape Changed for Pakistan?
por: Islam, Mahnoor
Publicado: (2020)

Extensively Drug-Resistant Acinetobacter baumannii
por: Doi, Yohei, et al.
Publicado: (2009)

A Large Cohort Study on the Clinical Value of Simultaneous Amplification and Testing for the Diagnosis of Pulmonary Tuberculosis
por: Yan, Liping, et al.
Publicado: (2016)

Increased Cytokines Response in Patients with Tuberculosis Complicated with Chronic Obstructive Pulmonary Disease
por: Tang, Shenjie, et al.
Publicado: (2013)

Risk Factors for Poor Treatment Outcomes in Patients with MDR-TB and XDR-TB in China: Retrospective Multi-Center Investigation
por: Tang, Shenjie, et al.
Publicado: (2013)

In vitro Synergism of Six Antituberculosis Agents Against Drug-Resistant Mycobacterium tuberculosis Isolated from Retreatment Tuberculosis Patients
por: Ying, Ruoyan, et al.
Publicado: (2021)

The TBAg/PHA ratio in T-SPOT.TB assay has high prospective value in the diagnosis of active tuberculosis: a multicenter study in China
por: Liu, Yidian, et al.
Publicado: (2021)

Longitudinally extensive transverse myelitis with mycobacterium tuberculosis infection
por: Fang, Le, et al.
Publicado: (2021)

Pulmonary Tuberculosis and SARS, China
por: Liu, Wei, et al.
Publicado: (2006)

Extensively Drug-Resistant Typhoid Fever: A Call to Action
por: Pustake, Manas, et al.
Publicado: (2022)

Mycobacterium tuberculosis Drug Resistance, Ghana
por: Owusu-Dabo, Ellis, et al.
Publicado: (2006)

Mycobacterium tuberculosis Drug Resistance, Abkhazia
por: Pardini, Manuela, et al.
Publicado: (2005)

Drug-resistant Mycobacterium tuberculosis, Taiwan
por: Jou, Ruwen, et al.
Publicado: (2006)

Extensive unilateral tuberculosis lung with segmental atresia of principal bronchus
por: Amita, Radhakrishnan Nair, et al.
Publicado: (2014)

Extensive unilateral pulmonary tuberculosis with segmental atresia of principal bronchus
por: Amita, R., et al.
Publicado: (2014)

Extensive unilateral pulmonary tuberculosis with segmental atresia of principal bronchus
por: Ray, Animesh
Publicado: (2015)

Characterization of antibody response against 16kD and 38kD of M. tuberculosis in the assisted diagnosis of active pulmonary tuberculosis
por: Hao, Xiaohui, et al.
Publicado: (2020)

Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman
por: Jaspard, Marie, et al.
Publicado: (2017)

Mycobacterium tuberculosis Complex Drug Resistance in Italy
por: Migliori, Giovanni B., et al.
Publicado: (2004)

Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, China
por: He, Xiao-chun, et al.
Publicado: (2017)

Drug-Resistant Mycobacterium tuberculosis among New Tuberculosis Patients, Yangon, Myanmar
por: Phyu, Sabai, et al.
Publicado: (2003)

Metabolic Profiles of Clinical Isolates of Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis: A Metabolomics-Based Study
por: Wang, Li, et al.
Publicado: (2023)

COVID-19 in Patients with Drug-Resistant Tuberculosis in Lesotho
por: Andom, Afom T., et al.
Publicado: (2023)

Laboratory-based Surveillance of Extensively Drug-Resistant Tuberculosis, China
por: Deng, Yunfeng, et al.
Publicado: (2011)

Distinguishing Nontuberculous Mycobacteria from Multidrug-Resistant Mycobacterium tuberculosis, China
por: Xu, Kaijin, et al.
Publicado: (2014)

Prevalence and Drug Resistance of Nontuberculous Mycobacteria, Northern China, 2008–2011
por: Wang, Xiaobo, et al.
Publicado: (2014)

Clinical practice of chest physicians for treatment of drug-resistant tuberculosis
por: De, Sajal
Publicado: (2012)

Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States
por: Winston, Carla A., et al.
Publicado: (2012)

Ethics, human rights and programmatic management of drug-resistant tuberculosis
por: Dholakia, Yatin N.
Publicado: (2012)

Drug-resistant tuberculosis: Response to More et al. (2017)
por: Basu, Saurav
Publicado: (2017)

Living and dying with drug resistant tuberculosis - Are we doing enough?
por: Mehta, Vibha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7le6s58pho9ar49d63ita0umsg